UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Retirement Guys Formula LLC

Retirement Guys Formula LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 34.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,513 shares of the healthcare conglomerate's stock after purchasing an additional 1,417 shares during the quarter. UnitedHealth Group comprises approximately 1.4% of Retirement Guys Formula LLC's portfolio, making the stock its 14th biggest position. Retirement Guys Formula LLC's holdings in UnitedHealth Group were worth $2,887,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG grew its holdings in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after buying an additional 9,872 shares during the last quarter. First Horizon Advisors Inc. raised its stake in UnitedHealth Group by 3.0% during the 4th quarter. First Horizon Advisors Inc. now owns 6,652 shares of the healthcare conglomerate's stock valued at $3,365,000 after acquiring an additional 194 shares during the last quarter. Finally, Wealthspire Advisors LLC grew its stake in shares of UnitedHealth Group by 4.6% in the 4th quarter. Wealthspire Advisors LLC now owns 13,977 shares of the healthcare conglomerate's stock valued at $7,070,000 after purchasing an additional 614 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

UNH stock opened at $300.85 on Tuesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock's 50 day moving average price is $353.44 and its 200 day moving average price is $460.22. The firm has a market cap of $272.91 billion, a P/E ratio of 12.60, a PEG ratio of 1.42 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the firm posted $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.94%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on UNH. Mizuho cut their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Raymond James Financial cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Baird R W lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Finally, TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $427.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.